🇺🇸 Infusion Therapy in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Blood Pressure Increased — 1 report (10%)
  2. Bronchitis Chronic — 1 report (10%)
  3. Cardiopulmonary Failure — 1 report (10%)
  4. Dehydration — 1 report (10%)
  5. Dizziness — 1 report (10%)
  6. Drug Ineffective — 1 report (10%)
  7. Drug Interaction — 1 report (10%)
  8. Feeling Abnormal — 1 report (10%)
  9. Gastroenteritis Rotavirus — 1 report (10%)
  10. General Physical Health Deterioration — 1 report (10%)

Source database →

Infusion Therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Infusion Therapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Infusion Therapy in United States?

Charite University, Berlin, Germany is the originator. The local marketing authorisation holder may differ — check the official source linked above.